Z, Z., F, K., F, J., J, J., D, Q., J, G., . . . X, X. (2025). RIPK1-targeted therapy alleviates intervertebral disc degeneration via inhibiting nucleus pulposus PANoptosis. Apoptosis : an international journal on programmed cell death, 30(11-12), 2868. https://doi.org/10.1007/s10495-025-02169-y
Chicago Style (17th ed.) CitationZ, Zhu, et al. "RIPK1-targeted Therapy Alleviates Intervertebral Disc Degeneration via Inhibiting Nucleus Pulposus PANoptosis." Apoptosis : An International Journal on Programmed Cell Death 30, no. 11-12 (2025): 2868. https://doi.org/10.1007/s10495-025-02169-y.
MLA (9th ed.) CitationZ, Zhu, et al. "RIPK1-targeted Therapy Alleviates Intervertebral Disc Degeneration via Inhibiting Nucleus Pulposus PANoptosis." Apoptosis : An International Journal on Programmed Cell Death, vol. 30, no. 11-12, 2025, p. 2868, https://doi.org/10.1007/s10495-025-02169-y.